Investment Firm Novo Names Moelis’s Kutay as New Chief Executive

  • Kutay starts in his new role in September based in Copenhagen
  • Novo manages more than 350 billion kroner in foundation assets

Novo A/S, the investment fund that holds stakes in health-care companies including Novo Nordisk A/S and Novozymes A/S, has hired Kasim Kutay from financial adviser Moelis & Co. to be its new chief executive officer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.